# Moderna, Inc.: Form 8-K, filed Feb 11, 2026

- Company: [Moderna, Inc.](/companies/mrna.md) (CIK 1682852)
- Form: 8-K
- Filed: 2026-02-11
- Accepted by EDGAR: Feb 10, 2026, 18:02 ET
- Period: 2026-02-03
- Accession: 0001682852-26-000012
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1682852/000168285226000012/mrna-20260203.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1682852/000168285226000012/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1682852/000168285226000012/mrna-20260203.htm

Filed Feb 11, 2026.
Source: SEC EDGAR, the filing index for accession 0001682852-26-000012. Last ingested by Listed: Nov 14, 2026, 18:43 ET. No prices; not investment advice.
